Matthew Slarve

Postdoctoral Scholar - Research Associate

Image of Matthew Slarve
Is this your profile? Click to edit

Publications

  • Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field. BioDrugs. 2026 Jul; 40(4):641-671.. View in PubMed
  • Characterizing the in vitro and in vivo effect of bicarbonate on azithromycin activity against Acinetobacter baumannii. PLoS One. 2026; 21(6):e0350230.. View in PubMed
  • A monoclonal antibody raised against Acinetobacter baumannii capsular carbohydrate exhibits cross-species in vitro binding against Pseudomonas aeruginosa. PLoS One. 2026; 21(1):e0340857.. View in PubMed
  • Evaluating antibody mediated opsonophagocytosis of bacteria via lab protocol: RAW 264.7 cell phagocytosis assay. PLoS One. 2025; 20(9):e0331445.. View in PubMed
  • Consistent Delivery of Adeno-Associated Virus via Lateral Tail-Vein Injection in Adult Mice. J Vis Exp. 2024 08 23.. View in PubMed
  • Clinical assays rapidly predict bacterial susceptibility to monoclonal antibody therapy. JCI Insight. 2024 01 23; 9(2).. View in PubMed
  • A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens. Sci Transl Med. 2023 10 04; 15(716):eadf9556.. View in PubMed
  • Development of a Bispecific Antibody Targeting Clinical Isolates of Acinetobacter baumannii. J Infect Dis. 2023 04 26; 227(9):1042-1049.. View in PubMed
  • Therapeutic, Humanized Monoclonal Antibody Exhibits Broad Binding and Protective Efficacy against Acinetobacter baumannii. Antimicrob Agents Chemother. 2023 03 16; 67(3):e0008623.. View in PubMed
  • Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis. Vaccine. 2022 07 29; 40(31):4160-4168.. View in PubMed